The influence of time from diagnosis to treatment on overall survival

Acute myeloid leukemia (AML) is often classified as an oncologic emergency leading to rapid evaluation and treatment in the hospital. Previous studies reported that time from diagnosis to treatment (TDT) had no impact on outcomes, but these data were limited to patients already intensively pretreated and/or not living in the US. A new study in adults with newly diagnosed AML, presented at ASH, comes to new conclusions.